Zhongda Hospital

This study tests whether adding a procedure called endovascular denervation (EDN) to standard treatments (TACE/HAIC plus immune-targeted therapy) can help people with advanced liver cancer that has spread to the portal vein and has not responded to initial therapy. About 62 adult…

This study tests whether adding two extra drugs to standard hormone therapy can more thoroughly shrink high-risk prostate tumors before they are removed. About 94 men with aggressive prostate cancer will receive the combination and then have surgery to check how much cancer remai…

This study tests whether adding the heart medication propranolol to standard hormone therapy before surgery can improve outcomes for men with high-risk prostate cancer. About 30 participants will receive the combination treatment before their prostate removal. The goal is to see …

This study will test a new type of endoscopic surgery to remove stomach tumors that grow outward from the stomach wall. About 20 people with these tumors will be treated to see if the procedure can completely remove the tumor and prevent it from coming back. The goal is to find a…

This study will review the medical records of 200 adults with heart failure, moderate-to-severe chronic kidney disease, and anemia who took roxadustat for at least a year. Researchers want to see if the drug improved heart function and reduced serious heart events. This is an obs…